skip to content

Early Cancer Institute

 
Read more at: Bringing science to life - Early Cancer Institute at Cambridge Festival 2023
Cambridge Festival Logo

Bringing science to life - Early Cancer Institute at Cambridge Festival 2023

20 March 2023

On Saturday 18 th March there was a definite buzz in the air around the Cambridge Academy of Science and Technology as people flocked to take part in the first in-person Biomedical Campus Open Day since 2019, one of the wide range of events organised for the 2023 Cambridge Festival . The Early Cancer Institute joined...


Read more at: Cancer Grand Challenges is inviting global research teams to apply for up to $25m funding and take on one of cancer’s toughest challenges

Cancer Grand Challenges is inviting global research teams to apply for up to $25m funding and take on one of cancer’s toughest challenges

7 March 2023

Applications for Cancer Grand Challenges open today, 8th March. Find out more


Read more at: Rebecca Fitzgerald receives OBE for services to cancer
Professor Rebecca Fitzgerald receiving her OBE

Rebecca Fitzgerald receives OBE for services to cancer

28 February 2023

Professor Rebecca Fitzgerald, director of the Early Cancer Institute, has received an Officer of the Order of the British Empire (OBE) for services to cancer. She was recognised in the late Queen's Platinum Jubilee Birthday Honours List in 2022, and received the OBE in Windsor in February 2023. Her research is focused on developing new ways to detect oesophageal cancer early and she has led pioneering advances in research and technological innovation to detect cancer earlier in order to improve outcomes for cancer patients.


Read more at: Daniel Muñoz Espín wins 2022 PROSE award
PROSE award

Daniel Muñoz Espín wins 2022 PROSE award

21 February 2023

Congratulations to Dr Daniel Muñoz Espín, whose new book has been awarded a prestigious PROSE award by the Association of American publishers (AAP). Since 1976 the PROSE awards have been honouring scholarly works in a number of categories across all areas of academic study. Daniel, Group Leader in the Early Cancer...


Read more at: $1million award to Harveer Dev and team
Photograph of Dr Harveer Dev

$1million award to Harveer Dev and team

1 February 2023

Congratulations to Dr Harveer Dev and a team from the University of Cambridge and the Knight Cancer Institute at OHSU who have been awarded a $1 million Challenge grant by the Prostate Cancer Foundation for their project entitled First-In-Man PARP1-selective inhibitor in lethal prostate cancer: mechanisms of action and...


Read more at: Caroline Watson awarded Milo Keynes thesis prize

Caroline Watson awarded Milo Keynes thesis prize

31 January 2023

Congratulations to Dr Caroline Watson, CRUK-funded Clinical Research Fellow (2017-2021) in the Blundell lab , who has been awarded the prestigious Milo Keynes prize by the University of Cambridge School of Clinical Medicine for the outstanding quality of her PhD thesis. Caroline's thesis was entitled The evolutionary...


Read more at: Planning permission submitted for East of England cancer hospital
Representation of proposed Cambridge Cancer Research Hospital

Planning permission submitted for East of England cancer hospital

26 January 2023

A full planning application to build a new specialist cancer research hospital for the region on the Cambridge Biomedical Campus has been submitted to Cambridge City Council. The new Cambridge Cancer Research Hospital (CCRH) will change the story of cancer. It will bring together clinical and research expertise in a new-world class hospital for the East of England to detect cancer earlier, treat it more precisely and save more lives.


Read more at: DNA graffiti: mutation patterns in cancer - watch the Francis Crick Lecture given by Serena Nik-Zainal

DNA graffiti: mutation patterns in cancer - watch the Francis Crick Lecture given by Serena Nik-Zainal

18 January 2023

Professor Serena Nik-Zainal was awared the Francis Crick Medal in 2022 and recently gave the prize lecture at the Royal Society. In the lecture, she explains that human cancers are highly individual. Etched into the DNA of cancers are graffiti-like mutation patterns, which could reveal underlying biological abnormalities, unique to each person’s cancer, with potential for application in precision medicine. You can watch the full lecture on the Royal Society YouTube channel.


Read more at: Understanding is in the mind of the beholder - communicating cancer risk across different audiences

Understanding is in the mind of the beholder - communicating cancer risk across different audiences

17 January 2023

The background that led to the development of the new Massive Open Online Course (MOOC) in risk communication from the CRUK Cambridge Centre is fascinating and, like many good things, arose almost accidentally out of adversity.


Read more at: Prostate cancer risk prediction algorithm could help target testing at men at greatest risk
CanRisk logo

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk

9 December 2022

Prostate cancer is the most common type of cancer in men. According to Cancer Research UK, over 52,000 men are diagnosed with the disease each year and there are more than 12,000 deaths. Now, Cambridge scientists have created a new, comprehensive tool for predicting an individual’s risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive the appropriate testing while reducing unnecessary – and potentially invasive – testing for those at very low risk.